The state of Washington currently has 14 active clinical trials seeking participants for Ulcerative Colitis research studies. These trials are conducted in various cities, including Seattle, Spokane, Tacoma and Vancouver.
A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease
Recruiting
This study aims to test the feasibility, acceptability, and preliminary efficacy of a comprehensive self-management (CSM) intervention for people with inflammatory bowel disease (IBD). The CSM-IBD intervention is an adaption of the CSM intervention initially developed for individuals with irritable bowel syndrome. The intervention has eight sessions which cover an introduction to IBD, symptom tracking, cognitive behavioral strategies, relaxation, sleep, diet, and pain management.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
03/16/2023
Locations: University of Washington, Seattle, Washington
Conditions: Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
The present study D5272C00001 (Legacy # 3151-201-008) seeks to evaluate the efficacy and safety of brazikumab versus placebo in patients with moderately to severely active UC and will include assessments of clinical responses as demonstrated by improvement of symptoms and of colonic mucosal appearance as observed on endoscopy.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
01/19/2021
Locations: Research Site, Seattle, Washington +1 locations
Conditions: Ulcerative Colitis